The Creatine Science Just Got Way More Crazy

Scientific concepts & claims about creatine

Dose–response, absorption, and self-experimentation

• Creatine benefits (e.g., sleep) can show measurable, statistically significant effects across different dosing conditions.
• Proposed absorption pattern (from the speaker’s self-experiment using sleep as the endpoint):
  • Creatine + salt on an empty stomach → best absorption
  • Creatine after a meal → worst absorption
  • Taking creatine ~1 hour before eating may loosen stool unless salt from the meal is paired with the dose.
• Standard dosing framework discussed:
  • Optional loading phase: ~20 g/day for 3–5 days
  • Maintenance: ~3–5 g/day
• Rationale behind this framework:
  • Loading is tied to rapid saturation of muscular creatine stores.
  • Without loading, muscle stores saturate in ~1 month with 3–5 g/day.
  • Long-term effects across many dosing permutations are not fully established by randomized trials.

Individual optimization method (step-by-step)

The speaker emphasizes tailoring based on measurable health goals rather than assuming one dose fits all:

1. Choose an endpoint/metric aligned with your goal (e.g., sleep, strength, speed, daytime function, feeling during the day, work output).
2. Start at a baseline dose of 3 g/day (minimum drawn from trials).
3. Track the metric until the effect stabilizes.
4. Increase dose by 1 g/day increments until you find the point of maximal benefit for that metric.

Example (sleep):

• ~20 g produced the largest sleep benefit
• 5 g gave about half
• Benefit increased roughly linearly from 5 → 8 g, then plateaued around ~8 g
• Therefore: long-term stabilization at ~8 g/day for that person’s sleep

Tolerance and possible micro-dosing

• Some people report GI side effects at higher doses.
• The claim is that if 3 g/day causes issues, it may be dose intolerance, not a need to avoid creatine entirely.
• Anecdotal example:
  • Tolerance allegedly developed with ~100 mg/day for ~3 months, followed by gradual increases.

Body weight and dosing

• Creatine dosing could be expressed per kilogram body weight.
• The speaker argues that the inter-individual spread across people is likely greater than the precision gained by per-kg calculation, so individualized titration still matters.

Brain/cognition and acute effects during sleep deprivation

A discussed study concept:

• Participants randomized to 20 g creatine vs placebo while sleep deprived, then tested brain puzzles.
• Described result: creatine reduced tiredness complaints and improved puzzle performance.

Limitations emphasized:

• Comparison was 20 g vs placebo, not vs lower doses (e.g., 5–10 g).
• Participants were not prior creatine users, which may differ from long-term users’ context.
• Creatine may have been taken/“sipped” overnight, potentially affecting brain availability differently than typical schedules.

Implication presented:

• Practical dose decisions should be grounded in your own long-term maintenance optimization, not only acute “light post” studies.

“Creatine is the energy grid” mechanism (mitochondrial energy distribution)

A central physiology argument:

• Mitochondria produce ATP; creatine helps redistribute/“grid” energy where needed.

Key mechanistic claims:

• Creatine phosphate diffuses through cellular water ~7–8× faster than ATP.
• Creatine shuttling back/forth with ADP is claimed to be faster than ADP handling via ATP diffusion.

Proposed shuttle at the mitochondrial boundary:

• Adenine nucleotide transporters/complexes near ATP synthase and creatine kinase enable efficient phosphate transfer.
• Muscle ATP/ADP dynamics: ADP stays associated with contracting machinery while creatine phosphate efficiently supplies phosphate back.

Organelles and specialized mitochondrial relevance:

• Creatine is portrayed as most relevant where mitochondria must spread energy over distance or where energy demand is highly variable.
• Examples raised:
  • Long cells/neurons: mitochondria differ by neuron region (cell body vs axon vs terminals) and appear to respond differently to drugs.
  • Some neuronal mitochondria may operate with ATP synthase in reverse, generating proton gradients.
  • Speculation: creatine could shuttle ATP/phosphate between mitochondria regions, potentially much faster (speaker mentions ~2000× as an implied order-of-magnitude concept).

Metabolic dysfunction, insulin resistance, and mitochondrial function (plausible link)

The discussion frames creatine as potentially relevant to:

• Mitochondrial function
• Metabolic dysfunction
• Insulin resistance / prediabetes

Mechanistic rationale given:

• Creatine supports ATP distribution and mitochondrial energy buffering, though exact clinical outcomes are not directly established by the referenced subtitles.

Gut physiology, energy demand, and GI effects

Creatine is argued to matter in the GI tract due to high energy requirements:

• Enterocyte turnover
  • Gut cells at microvilli tips last ~3–4 days, requiring frequent replacement → high energetic cost.
• Absorption requires gradients
  • ATP-powered ion gradients (often sodium gradients) drive nutrient uptake via transporters.
• Motility and hypoxia risk
  • Gut motility requires muscular action and helps avoid hypoxia in gut segments.
  • The gut is described as oxygen-sensitive because oxygen must diffuse from blood through layers, while digestion and the microbiome increase oxygen consumption.
  • If food sits too long, it can risk mitochondrial dysfunction (as presented).

GLP-1 receptor agonists discussion:

• The speaker suggests slowing gut motility (as GLP-1s do) could potentially increase hypoxia risk in some contexts, though some people might benefit from slowed motility.

Safety and “dependency” concern (autoregulation of creatine synthesis)

Addressing whether supplementation could permanently downregulate endogenous creatine synthesis (“dependency”):

• The speaker argues permanent shutdown is unlikely because creatine is infrastructure/support, not a signaling hormone like many drugs.
• A comparison is made to drug withdrawal:
  • Neurons adapt by changing “how they listen” to signals when neurotransmitter-affecting drugs are removed.
• The statement made:
  • No evidence was presented that creatine causes irreversible loss of endogenous production.
  • Glutathione is used as an analogy (raw material rather than a primary signaling compound).

Load vs long-term maintenance uncertainty

The speaker raises a possibility that “loading” may primarily:

• Saturate muscles quickly—potentially meaning early large doses might be “used up” by muscle uptake before brain benefits accrue.

They emphasize that results from people new to creatine may not apply to long-term users.

Researchers / sources featured

• Chris Masterjohn, PhD (named repeatedly; also associated with: chrismasterjohnphd.substack.com and mito.me)